Bladder hamartoma in Peutz-Jeghers syndrome: a rare case report

Abstract

Background

Peutz-Jeghers syndrome is an autosomal dominant disease characterized by mucocutaneous pigmentation and hamartomatous polyps in the gastrointestinal tract (GIT). There have also been cases of extra GIT polyps such as the renal pelvis, urinary bladder, lungs and nares. Bladder hamartoma is an extremely rare finding, with only 12 cases described in the literature up to now. The rarity of the condition necessitates a comprehensive compilation of managements up to now so as to provide a better tool for the treatment of such conditions in the future.

Case presentation

A twenty-year-old male, known to have Peutz-Jeghers syndrome, presented to us complaining of obstructive urinary symptoms. A urethrogram done showed a filling defect at the base of the urinary bladder. The mass was resected transurethrally, and histopathology revealed a hamartoma of the bladder. The patient has since remained tumor-free on follow-up.

Conclusions

Transurethral resection of the bladder mass proved to be an effective therapy in this patient with no recurrence on the patient’s follow-up till now. There is still, however, a dearth of knowledge regarding the management of bladder hamartomas owing to the extreme rarity of the case.

1 Background

Hamartoma of the urinary bladder is an unusual and very rare type of tumor. Only 12 such cases have been reported up to now. It is made up of a mixture of tissues resembling cystitis cystica, cystitis glandularis and von Brunn’s nests. The stroma may be edematous, fibrous or muscular. The 12 reported cases all had varying modes of presentation, which are documented in Table 1. However, a thorough search of literature was not fruitful in finding any diagnostic criteria of PJS in the urinary tract. It is generally benign after excision, and almost no recurrences have been reported. The mass can be identified by conventional imaging methods such as an ultrasound, an excretory urography or even a computed tomography (CT) scan; however, the final diagnosis is always histopathologic.

Table 1 Documented cases of bladder hamartoma in the literature. (TUR: transurethral resection)

2 Case presentation

A 20-year-old man with no reported co-morbids, previously known to have Peutz-Jeghers syndrome, was presented in our outpatient department with lower urinary tract symptoms (LUTS) for 3 months, which included straining on voiding, intermittency, urgency, and urge incontinence. He did not complain of any hesitancy, sense of incomplete emptying of the bladder, hematuria or passage of per urethral stone. Patient did not have any sexual history. He did, however, have a positive family history of tuberculosis. (His father had the disease when he was a child and had undergone full treatment course.) He had occasional episodes of diarrhea, owing to his Peutz-Jeghers syndrome (PJS), and normal sleep and appetite. Patient had had an endoscopic polypectomy, to confirm the diagnosis of PJS. He did not have any other significant surgical or medical history. On examination, the patient was of normal average built and height and comfortably lying down. General physical examination revealed hyperpigmented spots in his oral mucosa. There were no other striking features on the general physical examination. His blood biochemistry was within the normal range, whereas the ultrasound of the kidneys and bladder done showed a normal right kidney and a calculus of 5.6 mm in mid-pole calyx of the left kidney causing mild hydronephrosis and a very trabeculated bladder. Pre-void volume was 313 ml, and post-void was 113 ml.

Owing to the fact that the patient had obstructive lower urinary tract symptoms, a urethrogram was done, which showed a filling defect in the region of the bladder neck (Fig. 1). A provisional diagnosis of bladder mass was made, and the patient underwent cystoscopy, which showed multiple polypoidal growths at the neck of the bladder, a single central fibrotic band on the bladder diving the bladder in 2 halves and normal ureteric orifices. The polyps were resected transurethrally, and the specimen was sent for histopathology.. Later, he was followed in consultant clinic, and histopathology revealed a bladder mucosa exhibiting downward growing papillary architecture lined with transitional epithelium, representing a hamartoma of the urinary bladder (Fig. 2). No comment was made on tumor-free surgical margins. Postoperatively, patient was given injection mitomycin 40 mg intravesically, for one hour, since it was assumed at the time that the patient had a bladder tumor and treated as such. The patient was followed with a check cystoscopy, which was negative. He is scheduled to be followed with a check cystoscopy every 3 months to check for recurrence.

Fig. 1

Urethrogram showing a trabeculated bladder and a filling defect at the bladder neck

Fig. 2

Bladder mucosa exhibiting downward growing papillary architecture lined with transitional epithelium, representing a hamartoma of the urinary bladder. (H&E Stain, 20 × magnification.)

3 Discussion

PJS is a rare hereditary disorder, which is characterized by hamartomatous polyps in the gastrointestinal tract and typical pigment lesions [1]. Cases of extraintestinal polyps have been rarely reported in the literature. Possible sites of these polyps include the respiratory tract, urogenital tract [2, 3] and gallbladder [4]. There have also been general concerns regarding the malignant potential of the PJS, namely the LKB1 germline mutations [5]. Although a hamartoma is a benign condition, the diagnosis is only made after histopathology, and keeping in mind the malignant potential of hamartomas of the intestinal tract [6], a swift removal and biopsy of the bladder mass were needed.

The pathological definition of a hamartoma, irrespective of site of origin, is an abnormal proliferation of tissue indigenous to the organ to create a mass or tumor [7]. They can occur in a multitude of organs, including the spleen, liver, kidney and the lungs. They are, however, extremely rare in the urinary bladder [8, 9]. Since the first case reported by Davis in 1949 [10], only twelve cases (Table 1), to the best of our knowledge, have been reported in the literature up to now [11, 12], with only one case found in the literature associated with PJS [13]. Most cases tend to occur near to the trigone [8, 9], while the mass in our case was at the bladder neck. The patients can present with hematuria, pyuria, suprapubic discomfort [12] and now even obstructive LUTS.

Many treatment options have been suggested for such a lesion, but a transurethral resection (TUR) or even a partial cystectomy is the method which has been used in the literature [8]. There has been no evidence up to now that isolated bladder hamartomas, including invasive hamartomas, have any tendency for recurrence or malignant potential after partial cystectomy. With the rarity of the lesion, they set guidelines for the follow-up schedule of such patients. As such, certain reported cases have advocated cystoscopy to be done every three months for a year, then yearly for four years [13], a follow-up examination ranging from four months to five years [14], or simply a long-term periodic cystoscopy as surveillance—since the malignant potential of these lesions is as such unknown [11]. Our patient has had only one check cystoscopy done 3 months after the resection, and no growths were seen on check cysto. It is also worthwhile to mention that the patient received mitomycin 40 mg intravesically after his TURBT since he was thought to have a bladder mass at the time and treated as such.

4 Conclusion

Transurethral resection of the bladder mass, followed by intravesical mitomycin, proved to be an effective therapy in this patient with no recurrence on the patient’s follow-up till now. Follow-up regimens have been varied in different cases, but with the unknown potential of the lesion, with only 13 cases reported, there is still, however, a dearth of knowledge regarding the management of bladder hamartomas owing to the extreme rarity of the case and, as such, is being followed up very stringently every 3 months.